Cardiac Sympathetic Dominance and Systemic Inflammation in COPD

Area of Science:

• Cardiology
• Pulmonology
• Autonomic Nervous System Research

Background:

• Cardiac autonomic dysfunction is a key factor in adverse outcomes across various diseases.
• Existing literature on autonomic nervous system changes in chronic obstructive pulmonary disease (COPD) is inconsistent.
• The relationship between autonomic dysfunction, systemic inflammation, and cardiovascular issues in COPD requires further investigation.

Purpose of the Study:

• To investigate the cardiac autonomic activity in patients with COPD.
• To explore the association between autonomic dysfunction, systemic inflammation, and physiological parameters in COPD.
• To determine the sympathetic and parasympathetic balance in COPD patients.

Main Methods:

• Sixty-three stable COPD patients and 36 controls underwent spirometry, diffusion capacity tests, and the six-minute walk test.
• Serum levels of interleukin-6 (IL-6) and high-sensitivity C-reactive protein were measured.
• Cardiac autonomic activity was assessed using heart rate variability (HRV) recordings and averaged heart rate.

Main Results:

• COPD patients showed increased overall autonomic modulation, with higher heart rates indicating sympathetic dominance.
• Heart rate was inversely correlated with lung diffusion capacity.
• Interleukin-6 (IL-6) levels were inversely correlated with parasympathetic activity (pNN50) and positively with the sympathetic:parasympathetic balance (LF/HF ratio).

Conclusions:

• Patients with COPD experience heightened cardiac autonomic modulation, characterized by sympathetic dominance.
• This autonomic imbalance is linked to diminished lung diffusion capacity and elevated systemic inflammation.
• Autonomic dysfunction and inflammation may contribute to cardiovascular morbidity in COPD.